Member Info for _Mr_Big

Sir_digby - no need for such aggression.
That's very antisemito-homophobo-trollo-phobic of you.

Come on Ritchie, creating an account on this board just to sing your own praises is too low, even for you.

A court case would have to be RNSed too.

Not sure how to take today's RNS. Either very good or very bad, but wtfdik, I'll just hold.

That's not how pmes work...

boyg - probably a bump before a placing to fund more trials ;)

You heard what you wanted to hear - I heard what he actually meant.

- You must be excited about commercialisation, Richard?
- Well, a lot of our investors are here just to feel good about saving the world, but yes, there are some who want the monetary return too. [We don't cater for their kind].

Was it not supposed to be resolved/escalated within a 28 day period?

What a waste of time. Even Katie couldn't make this bearable.

The company's USP was that we can send you an easy-to-administer early home treatment. They now had to make a u-turn on that USP, because they found out the drug is better off administered later in the course of the illness (an idea that initially took them by surprise when the hospital arm results came in). If there's not enough patients with significant breathlessness in Activ-2, then it will fail to collect any significant data, just like the HT did.
If there's not enough patients with significant breathlessness in P3, the trial will also fail, but it's unlikely considering the criteria for participation. Big question is, if regulators were happy to talk about approvals on the back of a 220+600 participant data, what are they going to say if P3 returns, say, optimistically, 500 "valid" data points +69 from P2. That's 70% of the target population. What's then? SNG trying to change the rules of the game after the game has already started?Approval or more trials? Your guess as good as mine.
Effectiveness is still not 100% guaranteed anyway, because it took the scientists months to come up with a way to manipulate the failed P2 data to actually get a positive story out of it (on the back of 69 participants picked out of 220), hence the long faces in the last presentation.

It would, of course, help if the company PRed some clarity around the dispute and the private sales, but I guess that's too much to ask.

Selling now makes no sense, unless you know something that the rest of the market doesn't...

If this drug makes it, that would be despite Marsden.

This is like nominating the fat & ugly chick to be the prom queen, just to dump pig blood on her, like in that netflix movie. What was it called? Christine?

"Chief executive of the year award"

PMSL.

Schrow - firstly, it's a free board - if you don't like an alternative point of view, f* off to the reddit page.

Secondly, what makes you think Activ2 will be a blast when SNG failed HT?

I'm just here to keep scinv company in fighting the evil cult ****s anyway.

Ghia - the cult appears to claim that nobody in the world is allowed to treat covid with a bung without paying SNG money because SNG were the first to patent the idea of treating covid with a bung. I've seen this being chanted by the cult quite often. Therefore no competition is possible. Again - misinformation from the cult to mislead the clueless Joe Investor.

Where's that guy who was saying 300m mcap was way too low a couple of weeks ago?

For a covid stock that does not expect to generate revenues until about this time next year and will quite possibly fail Activ2.

Mcap's way too high for 69 data points boys and girls.

You think derampers are bad, but it's the rampers you need to be afraid of.
It's like that old song by pink floyd. You think the dogs are your enemies, but it's the pigs running the farm.

Tony, how do these patents fit into your charts?